Published in Blood Weekly, January 12th, 2006
"The performance of the m1000 system (Abbott Laboratories, Illinois) as a front-end extraction system for high-throughput in-house quantitative real-time PCR assays was analyzed and compared to that of manual extraction of plasma and serum samples HCV and hepatitis B virus (HBV) and EDTA-blood samples (cytomegalovirus [CMV] and Epstein-Barr virus [EBV])."
K. Beuselinck and colleagues, Catholic University of Leuven, wrote, "Linearity of extraction was tested on dilution series of HCV and HBV reference...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-01-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.